Novartis India Forms Death Cross, Signaling Potential Bearish Trend Ahead
Novartis India Ltd, a small-cap pharmaceutical company, has recently encountered a Death Cross, indicating potential bearish market sentiment. With a market cap of Rs 2,158.00 crore and a P/E ratio significantly below the industry average, the stock has underperformed over the past year, facing ongoing challenges reflected in various technical indicators.
Novartis India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and a bearish trend.Currently, Novartis India has a market capitalization of Rs 2,158.00 crore and a price-to-earnings (P/E) ratio of 20.74, which is notably lower than the industry average of 35.71. Over the past year, the stock has underperformed, showing a decline of 18.20%, while the Sensex has gained 5.18%. In the short term, Novartis India has also faced challenges, with a 1.50% drop today compared to a 0.41% decline in the Sensex.
The technical indicators paint a bearish picture, with the MACD and Bollinger Bands reflecting negative momentum. The stock's performance over various time frames, including a 3-month decline of 14.93% and a year-to-date drop of 6.13%, further emphasizes the challenges it faces in the current market environment. Investors may want to closely monitor these trends as they could have implications for future performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
